|
Number of patients
|
84
|
56
|
|
Sex: male
|
76 (90%)
|
51(91%)
|
|
Age (median, range)
|
43 (24 - 70)
|
41 (24 - 62)
|
|
Rise factor
| | |
|
Haemophilia
|
56 (67%)
|
35 (63%)
|
|
i. v. drugs
|
22 (26%)
|
16(29%)
|
|
man who have sex with man
|
6 (7%)
|
5 (9%)
|
|
HCV-RNA negative
|
14(17%)
|
5 (9%)
|
|
HCV viral load > 800000 1 U/1
|
55 (66%)
|
39 (70%)
|
|
HCV-Genotype
| | |
|
1
|
52 (62%)
|
39 (72%)
|
|
2
|
6(7%)
|
3 (6%)
|
|
3
|
13(16%)
|
10(19%)
|
|
4
|
4 (5%)
|
2 (4%)
|
|
HAART
|
67 (82%)
|
46 (84%)
|
|
PI-based HAART
|
50 (75%)
|
37 (80%)
|
|
NNRTI-based HAART
|
17 (25%)
|
9 (20%)
|
|
< 50 HIV copies/ml
|
62 (74%)
|
43 (77%)
|
|
CD4-Count (median, range) [cell/μl
|
397 (10 - 1757)
|
394 (10 - 966)
|
|
AST (median, range) [U/l]
|
47 (21 - 197)
|
48 (21 - 197)
|
|
ALT (median, range) [U/l]
|
72 (8 - 275)
|
77 (16 - 275)
|
|
Platelets (median, range) [T/l]
|
160 (9 - 337)
|
148 (9 - 325)
|
|
Stiffness (median, range) [kPa]
|
7.4 (3.3 - 48)
|
7.8 (3.3 - 48)
|
|
APRI (median, range)
|
n = 75
|
n = 52
|
| |
0.9 (0.3 - 43.2)
|
11.1 (0.4 - 43.2)
|
|
FIB-4 (median, range)
|
n = 75
|
n = 52
|
| |
11.6 (0.5 - 50.3)
|
11.6 (0.5 - 50.3)
|
|
IL28B genotype:
| | |
|
CC
|
42 (50%)
|
26 (46%)
|
|
CT
|
36 (43%)
|
25 (45%)
|
|
TT
|
6(7%)
|
5 (9%)
|
|
Time of follow-up (median, range) [months]
|
25 (5 - 50)
|
